2012, Volume 5, Issue 2, pp 192 – 195

Pharmacological therapy in patients diagnosed with Peyronie’s disease
All issues » 2012 » Issue 2 » Case Presentation

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Halal AA *

Geavlete P **

Ceban E ***

* MEDAS Medical Center, Bucharest

** “Sf. Ioan” Clinical Emergency Hospital, Department of Urology, Bucharest

*** "Nicolae Testemişanu" USMF, Chișinău, Republic of Moldova

Correspondence to:Petrişor Geavlete, MD, PhD Department of Urology, “Sf. Ioan” Clinical Emergency Hospital, 13 Vitan Barzesti Street, District 4, Code: 042122, Bucharest, Romania Phone/fax: + 40 21 334 5000; E-mail: geavlete@gmail.com

Abstract

Peyronie’s disease is still a therapeutic dilemma for the urologist. Although medical treatment includes multiple versions, few therapeutic agents had significant effects. The combination between oral therapy and intralesional agents can improve the quality of life of the patients with Peyronie’s disease.

Keywords

Peyronie diseaseverapamilvitamin Ecolchicine

Preview

JMedLife-05-192
Download PDF

About this article

PMC ID: 3391879
PubMed ID: 22802890
DOI: 

Article Publishing Date (print): 12-06-2012
Available Online: 18-06-2012

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues